As an impending third wave stares at us in the face here in India, concerns are being raised regarding the effectiveness of existing vaccines against the new variant, Omicron. One of the primary questions being asked is whether the Oxford-Astrazeneca vaccine, Covishield, can put up a fight against the highly contagious variant. While there is a long way before conclusive evidence comes to light, some studies do provide some information and a possible answer to the ‘Covishield vs omicron’ debate.
Before we find out how effective a tool Covishield is, we should be abreast with what we already know about the new variant. Omicron‘s roots can be traced back to South Africa, where the first case was detected. Since then, it has traversed the world and spread like wildfire. This confirms one thing: the rate of spreading is very high this time.
The first case in India was found in December in Karnataka. The variant has started to engulf large parts of the subcontinent as well. While the severity of this variant is yet to be confirmed, there has been a lot of talk surrounding the role of vaccines in fighting this wave. Many opine that to battle omicron, Covishield might be the weapon we need.
In a study done at Oxford last month, it was revealed that those who had taken 3rd dose of Covishield had a higher antibody level. Previous studies had talked at length regarding the effectiveness of a two-dose vaccination against the Delta variant. Although done on a small sample of 41 people, the recent study shows that three doses do increase the chances of increased effectiveness of covishield against omicron.
More studies suggest that two doses of the AstraZeneca vaccine, coupled with a booster shot, offer 70-75% efficacy against the new variant. Hence, with time and more surveys, the question of ”is Covishield effective against omicron” will get its due answers.
As of 5th January 2022, 61.5 crore people in India have been fully vaccinated with two doses, which accounts for 44.5% of the total population. Children belonging to the 15-18 year age group have also started receiving the first dose of Covaxin. The aforementioned Oxford study may suggest that a booster shot is the way to go, but the fact remains that more than half of India’s population is yet to be fully vaccinated.
Keeping the sudden surge in cases in mind, the government has decided to begin giving boosters to health workers, frontline workers and those above 60 years of age with co-morbidities from January 10, 2022. This was a crucial and much-needed step. Possibly, all other age groups too will soon afterwards come under the ambit of the third dose. But more importantly, the country should want to make sure everyone receives their first two doses. So, if you are yet not fully vaccinated, book your slot right away.
Also Read: Is Covaxin Effective Against Omicron?
As you wait your chance in line for your booster in the form of covishield, omicron will continue to rage outside. Therefore everyone would be best advised to keep on adhering to the safety measures. These include:
You might come across news clippings and primetime shows with headlines asking ”does covishield work against omicron”. In reality, we all need to wait for some more time before we can say anything with certainty. But there is no doubt that the vaccine is in fact the first step towards curbing this pandemic. Stay cautious, stay safe and save lives.
Also Read: Precautions Against The Omicron Variant
Disclaimer:
The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
The Delta variant of COVID-19 was detected back in April 2021 in India. It was particularly dominant in Maharashtra, Kerala and Madhya Pradesh. As a result, government regulations have tightened the restrictions and in many parts of these states, lockdowns have been observed in the last 2 months.
There was widespread scepticism regarding the efficacy of the Covaxin and Covishield vaccines against this new variant. However, a recent study has revealed that Bharat Biotech’s Covaxin is indeed quite effective against the new Delta Plus variant of the coronavirus.
Covaxin, which is essentially a whole-virion inactivated SARS-CoV-2 vaccine, was found to be effective against the earlier Delta variant. Even during the second wave, which was mainly caused by the Delta variant, this vaccine proved to be 65.2% effective in protecting vaccinated people from the virus. Studies had been conducted in a double-blind, randomized and multicentre phase 3 clinical trial which had shown that the mass inoculation drives using Covaxin had been highly effective in controlling the spread of the earlier Delta variant.
Since Covaxin had earlier proven effective against the Delta variant, it is highly possible that it has a similar potency against the Delta Plus variant. The recent study in question was conducted by the Indian Council of Medical Research and has been recently published in the online research repository known as bioRxiv. The study stated that the natively developed Covaxin of India has been deemed effective against the Delta Plus variant. It concluded that Covaxin has shown 77.8% efficacy against symptomatic COVID-19 which is a phenomenal breakthrough discovery since this gets one step further in flattening the curve.
Since there has been great confusion regarding the extent to which Covaxin can be effective against this new variant, this study has shed light on certain facts and helped put many vaccinated people at ease. It was earlier speculated that the Delta Plus variant, which contains a mutation of the K417N spike protein can probably escape the immune response generated by the vaccines. Virologists and doctors were anxious that this new variant could surpass the effect of antibody response, thereby rendering Covaxin ineffective. However, with this new study, vaccinations using Covaxin can continue throughout the country as it shows a modest level of efficacy against the Delta Plus variant as well.
While the efficacy of Covaxin against the original variant of COVID-19 was reported to be 81%, that of the Covishield was reported to be 90%. As a result, many preferred the latter over the former homegrown vaccine. However, with the emergence of new variants like the Delta and the Delta Plus, it is seen that the effectiveness of both Covaxin and Covishield have been reduced.
A study published in the New England Journal of Medicine suggested that AstraZeneca’s Covishield, which has similar properties to that of Covaxin, is 67% effective against the new Delta and Delta Plus variants. In comparison, India’s very own Covaxin is about 65.2% effective, meaning there is not much difference between the efficacy of both.
COVID-19 vaccinations have been faced with mixed reactions from people along with typical rumours of being a placebo. However, such is usually the case with any medical or scientific breakthrough in its initial stages. As someone who has already been vaccinated, you must remember that these vaccines have undergone extensive human trials by now and new studies are being published frequently about their increased efficacy. Therefore, if you have already been vaccinated, you can rest assured that your vaccination has not been in vain.
Another factor to consider is the protection that vaccines offer despite not having a 100% prevention rate. As late as Jan 2022, vaccines were shown that not only do all vaccinations provide protection against severe symptomatic disease, it also protects against hospitalisation for Covid-19. In turn, several studies have shown that hospitalisation and death rates from Covid-19 are much lower in those who are vaccinated vs those who aren’t. Additional data coming in also shows that a booster shot (a third shot of the vaccination) also adds to this type of protection.
Even though these new studies have proven that Covaxin or any other COVID-19 vaccine for that matter, provide a decent amount of protection against the virus, none of them has 100% efficacy. Therefore, it is important that despite being vaccinated, we still follow all necessary COVID-19 protocols in order to prevent any future waves of this virus.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
2022 comes with the hope of a better and healthier future for us all. India is on its way towards complete vaccination. Under-18 vaccination too has started. This means we are one step closer to defeating COVID-19. But that does not mean we should drop all precautions. New variants and even hybrid infections are on the rise. You need not worry as long as you are cautious. In this context, it is essential that we all learn a little more about Flurona, which has been making headlines all over the world. The start of 2022 has been marked with fresh news about the emergence of two new threats. We already know that a new wave brought on by the Omicron virus (first detected in South Africa) is right around the corner unless we are all very cautious. But it has emerged that there could be another threat looming in the distance. The new danger that has got scientists anxious is flurona. What is flurona and what is it capable of doing? Read on to find out.
Flurona was found in the body of a pregnant woman in Israel when she was hospitalized to give birth.
Flurona is not a strain of COVID-19. It is actually a term used for the illness caused by 2 infections at the same time in the same person- one being the seasonal Flu and the other being COVID-19. That means, her body was harbouring both the seasonal flu virus and the coronavirus at the same time. It is a case of double infection.
She tested positive for both the Flu and COVID and the diagnostic tests were carried out more than once for confirmation. Her symptoms were mild. The woman had not been vaccinated for COVID-19. Because her symptoms are mild, she will be discharged soon as per news reports.
The infection thus caused is also a viral infection and contagious. Scientists believe this happened because this is the Flu season and the human body is capable of sustaining both kinds of viruses at the same time.
The symptoms of flurona are the same as the Flu or COVID-19 because it is also an upper respiratory tract infection. It triggers fever, sore throat, body ache, fatigue and breathing difficulty.
Will flurona be more dangerous than the strains of COVID-19?
This is too early to state anything about the severity of this dual infection. With more information and studies, we are likely to receive a clearer picture of the spread and threats associated with flurona.
COVID appropriate behaviour can save us from exposure to both infections. Do not forget these points-
In the upcoming days, we cannot let caution and care slide. Omicron is already here and delta has not gone yet. Life must indeed go on, but we must adopt every precaution possible. Masks, sanitisers, social distancing and following government circulars on safety should once again be part of our lives. A lit bit of caution never hurts anyone. It can in fact save lives. The safety of each and everyone is our collective responsibility at this time. Let’s do our bit to reduce the transmission of Covid infection.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
Amidst alarming news of COVID-19 cases increasing in India due to the Omicron variant, there is a ray of hope in the New Year with the government rollout of vaccines for children, frontline workers and senior citizens. The new vaccination drive which is to begin from 3rd January 2022 for teens aged 15-18 years signifies that every cloud has a silver lining.
To know more about the current scenario, what the government is planning and what you should do to stay safe read the article below.
Addressing the country on 25th December 2021, the honourable PM announced that The Drug Controller General of India (DCGI) has approved the emergency use of the indigenously developed Covaxin for immunising young adults. Aside from Covaxin, ZyCoV-D developed by Zydus Cadila has also been authorised for emergency usage. However, the vaccination drive as of now will only cover children in the 15-18 years age bracket and Covaxin will be administered to them. Designed as a precautionary measure to protect the future of the Nation from the impending harm of the new variant, guardians as well responsible youths are urged to get their children and themselves registered respectively on the Co-WIN Portal.
As of now, the authorised COVID-19 vaccine for under 18 in India is slated to be only for Covaxin.
Frontline workers i.e., employees who have to be physically present at their jobs such as doctors, fire-fighters, policemen and other kinds of industry professionals were the first to get their jab last year when the vaccination drive started followed by senior citizens (with co-morbidities). To make sure that everyone is safe in the face of the omicron virus surge, the Government has announced and emphasised that these two groups will be once eligible for a booster vaccine dose called a precaution dose from January 10th 2022. To get the jab, registrations are required to be made on the portal once again. For safety concerns, senior citizens are advised to go ahead with the booster dose upon confirmation from their respective healthcare providers.
As of reports released on 3rd January 2022, the Union Health Ministry announced that the Omicron variant cases were 1,700 in the country with an infection radius of 23 states and union territories. Delhi itself recorded 84% of new infections in the last few days. Currently, Delhi is functioning with a ‘yellow alert’ category of restriction under which educational institutions, gyms, theatres and shops involved in the trade of non-essential items are meant to stay shut until further notice.
However, as per studies conducted by doctors, the Omicron variant is said to only bring about mild infections with little requirement for oxygen concentrators and hospitalization, unlike the Delta variant.
The trend shows that those without vaccination are likely to suffer a more painful infection as opposed to those being doubled vaccinated.
Another trend being noticed is that in most cases of the infection, the individual is asymptomatic, meaning that he/she wouldn’t know that they are infected and will unknowingly spread the viral infection when in close contact with others. Keeping this fact in mind, civilians are being asked to be cautious and follow all COVID-19 appropriate behaviour. This includes limiting going out in public spaces and spending the rest of the winter season in a low key manner. As per news reports, the festive season during December was one of the main drivers behind the surge in Europe and also why COVID-19 cases are increasing in India and so now there is a necessity to salvage the situation before it goes totally out of hand.
Although the Omicron variant is spreading quite fast, the good news is that India will see a surge by the end of January which means that the lifespan of this infection is going to be short-lived. In the meanwhile, it is advised that you get your children and elderly family members vaccinated and follow COVID-19 mandates at all times. Follow all safety precautions in order to save yourselves and others from the risk of exposure to COVID-19 infection.
Disclaimer:
The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
The Omicron wave is looming and India must prepare itself to deal with another possible outbreak, this time triggered by the new COVID-19 variant called Omicron. But before you start to despair, let us tell you that you can keep yourself safe from it. And it starts with awareness. COVID cases are indeed increasing in India. But why? Is it just because Omicron is very contagious or is something else behind it? Read on to find out.
The second wave that was caused by the Delta had abated by October. India started registering very few cases since October. Naturally, most of us thought that the worst of COVID-19 has passed.
But in late November 2021, South African scientists identified a new variant which was named Omicron or B.1.1.529. This is by far the most infectious COVID-19 variant and very soon Omicron cases began to be reported in other countries of Africa, Europe and the Americas.
In early December, Omicron reached India. By December 31st, India crossed the 16,000 Covid cases mark, for the first time in 4 months. With 16, 764 cases being reported on 31st December, India has logged the highest case count since October. The number has been rising steadily since then. According to the Union Ministry of Health, the Omicron case tally, for now, is 1700.
Densely populated states and cities naturally rank high. Maharashtra and the NCT have more Omicron cases than the rest of the country. By December 31st, Delhi recorded a 42% increase, and Mumbai a 46% increase from the previous day.
The positivity rate, for now, is 1.87%. According to WHO, this rate should be below 5%. Once the 5% mark is crossed, containing the spread becomes immensely challenging.
Maharashtra, the NCT and Karnataka hospitals have been admitting a steady stream of COVID-19 patients, the number being higher than that of the last few months. The good news is most of these people are recovering well. This is in keeping with what has been observed in South Africa and the UK.
So far, there are no reports on the severity of illness in cases of COVID-19 caused by omicron among the vulnerable population (babies and people with comorbidities).
One reason why COVID cases are increasing in India is that Omicron is highly transferable. As soon as it arrived in India, experts knew that it would spread and there would be a risk of the third wave. Caution was sounded.
However, not all cases of COVID-19 being recorded are triggered by Omicron. So why did COVID cases abate and then pick up again?
The most obvious reason is our complacency. As soon as the second wave receded, people began to relax COVID-19 precautions. Even the previous variants like Delta are still spreading and causing infections. When we do not mask up, sanitize or wash up, we make ourselves and everyone else vulnerable to an infection caused by any COVID-19 variant.
The increase in travelling and gatherings during the winter festive season has been a contributing factor in the spike of Covid cases everywhere.
Also Read: What Precautions to Take Against Omicron Variant?
The Union Government and state governments (such as West Bengal) have already released or devised new COVID-19 circulars outlining the restrictions that have or will come into force. Common guidelines you may expect include operating trains and metros at 50% capacity, quarantine zones, work from home wherever possible, 50% attendance in offices, night curfews, restriction of flights, etc.
Now the onus is on every one of us to be cautious. Only by being prudent will we be able to keep ourselves safe from Omicron, the other variants of COVID-19 and from the third wave. Let us not be complacent just because Omicron is likely to be less dangerous than the other variants. The threat is serious. The third wave is at our doorstep and for the next few weeks, we must all observe every COVID-19 precaution.
Studies predict that unless we are careful, the third wave caused by Omicron may result in 150% more cases than the second wave. Such a caseload would overwhelm our healthcare services.
For age 15 to 18 COVID vaccines are being administered now. So please get your child registered for the vaccine. If you are yet to receive full vaccination, make sure that you get both doses as soon as possible. Vaccination can save lives.
Also Read: Is Covishield Effective Against Omicron Variant?
Let us all recall the horrors of the second wave. It is fresh in our collective memory. Let us make sure that there is no repeat of that. For the sake of our loved ones, and our country and world at large. We can all try to be cautious in the upcoming days. Cancel your holiday plans (if possible), and avoid crowds because health is more important right now than enjoyment.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
Omicron has already started creating chaos, and now people are wondering if they are going to experience the same mayhem the Delta variant of COVID-19 had caused earlier in 2021. Well, if you are also terrified of going through the same agony again, here is good news for you!
As per the initial research and studies, the Omicron variant of COVID-19 poses 50 to 70 per cent fewer chances of hospitalisation as compared to the previous strains. They, however, have cautioned to be careful as it still has the potential to lead many people to the hospitals. Following safety protocols sincerely can help us in minimising the spread of this wave.
The UK Health Security Agency has claimed that the initial results of the research suggest that most of the infected people would recover without any hospital care but still, the variant can cause a lot of damage.
Defining the reason behind the potential threat, the experts explained that the Omicron variant spreads way faster than the Delta variant and also has the capability to dodge the vaccine, which the earlier strains were unable to do. Hence, it may infect a larger number of people and hence, can cause too many hospitalisations.
Studies conducted across all the countries including England, South Africa, Scotland and Denmark have shown similar results. All of them have accepted the new strain to be far more contagious but milder in terms of symptoms. It is important to know that it can also cause moderate to severe illness as well as death.
The United Kingdom has been one of the worst affected countries in terms of Omicron spread as of now. Since November this year, a total of 132 people have been admitted to the hospital after contracting the Omicron variant. Out of these, 14 people have died within 28 days of being infected.
The study has highlighted some interesting insights. Have a look:
The concerning thing is that the virus may be causing milder symptoms but this advantage may go down the drain because of its higher contagiousness.
Moreover, the experts are still not sure what this strain is going to do with the older people, people with comorbid conditions, unvaccinated population. Due to the high rate of transmission, it can burden the healthcare system and cause a lot of problems if taken lightly. The threat of delta is not over yet, as it is still the dominant variant.
Also Read: Is Covishield Effective Against Omicron?
Omicron has been presenting itself with milder symptoms because of the combination of people’s immunity and certain changes to the virus itself.
The initial studies have found out that most of the people who have contracted the new variant have been infected before with the previous variants or have already taken the vaccination. Both of these qualities provide a robust defence mechanism against the virus.
The lab studies have also shown that the way the Omicron variant infects our body is also different from the Delta variant. Unlike its predecessor, Omicron infects the airways of the person instead of messing up the deep tissues of the lungs, which makes it easier for it to spread, but milder as it stays away from the delicate parts of the lungs.
The precautions and steps to be taken remain the same as before. It is essential to mask yourself properly, take both doses of vaccines (if not yet vaccinated), maintain physical distancing, follow hand hygiene, respiratory etiquettes and maintain good ventilation to the maximum possible.
The Omicron variant may be able to cause breakthrough infection but vaccinations do prevent the chances of severe infection. Hence, vaccination is still our best shield against this or any upcoming variant of COVID-19.
Read More: Precautions to Take Against The Omicron Variant
Omicron for sure is here to modify our New Year plans, but with a little caution and determination, we surely can protect ourselves and our loved ones from this virus and finally push COVID-19 to the endemic stage, where it was supposed to be by the start of the year 2022. So, please keep wearing masks and avoid large gatherings till instructed otherwise. Stay safe and happy.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
The Serum Institute of India (SII) sought and received approval from the World Health Organisation on the 17th of December, 2021 for the emergency use of Covovax. SII is one of the largest vaccine manufacturers in the world and WHO approved the Emergency Use Listing (EUL) of the COVID-19 vaccine Covovax, which was developed under the licence of Novavax. This is the recent vaccine associated with India, that has been approved by the WHO, the other two being Covaxin and Covishield. This vaccine has been approved for immunisation of individuals who are 18 years and above.
The fight against COVID-19 is ongoing and vaccinations for the entire population is the need of the hour. When vaccines against COVID-19 were first introduced to the world, many third world nations like India suffered from vaccine shortages. The manufacture of Covaxin (India’s first indigenous vaccine) and Covishield (the Indian version of Britain’s AstraZeneca) were major milestones for the efforts to vaccinate India.
The approval of Covovax in India by the WHO is an important milestone because more people can now get vaccinated (especially in lower-income nations). This indicates that there are now 9 (Covovax being the 9th one) COVID-19 vaccines that can help us stay protected from the virus. The approval of the vaccine is a positive indicator of the safety and protection of the people from SARS CoV-2.
The approval of the Covovax vaccine by the WHO is a strong indicator of its efficacy and safety. It is important to know whether a vaccine is showing effectiveness or not. Covovax has been developed using the technology of the Novavax vaccine, which is effective in providing protection against the mutated strains of the COVID-19 virus. Since the Covovax vaccine has been deemed safe for use, it means that more people can now get vaccinated and stay protected against mutated strains as well. A projected third dose can increase the antibody count by up to 4-6 times and provide resistance against the delta variant. Studies about the protection against the omicron variant are still ongoing.
SII CEO Adar Poonawalla has announced plans for the launch of Covovax jabs for children too. He plans to launch a vaccine for children from the age of three. Although children have not faced any deadly effects of the virus, vaccinating them ensures a safety net for them.
COVOVAX is the protein-based COVID-19 vaccine option, with demonstrated efficacy and a well-tolerated safety profile, to be made available through the COVAX Facility said CEO of Serum Institute of India, Mr Adar Poonawala. The Covovax vaccine uses spike proteins to help the immune system adapt to combat the virus and create antibodies.
Covovax requires storage between the temperatures of 2 °C and 8 °C, therefore existing cold chain supply lines for vaccine transport can be used for this vaccine as well.
Clinical studies show a 96.4% efficacy against mild or severe COVID-19 infection. The Covovax vaccine has a very strong safety profile and the booster shots are deemed to be more effective. Although more study is required to understand the vaccine’s efficacy against the Omicron variant. However, the INSACOG (Indian SARS-CoV-2 Consortium on Genomics), does believe that there are high chances that Covovax will receive approval as the booster shot that we may all need.
Children need the COVID-19 vaccine as much as adults do because they are returning to schools and colleges and they are vulnerable without the protection offered by vaccines. So can Covovax be administered to children? According to Poonawalla, Covovax is safe and can offer the required protection to all children down to three years of age.
The approval of Covovax by the WHO is a boost for India’s vaccination drive. It is also a positive indicator that studies to understand and counter the COVID-19 virus are being effective. Serum Institute of India also plans to introduce a vaccine for children based on Covovax. You can stay assured that Covovax is an effective measure to protect yourself from mutated strains of the virus. It is important for everyone to get vaccinated, follow covid-appropriate behaviour and maintain a safe distance from others to reduce the risk of exposure to COVID-19.
With 2021 coming to an end, a new COVID-19 variant has posed a threat to the resumption of normalcy. This variant, the B.1.1.529, popularly known as the Omicron variant, is now being studied closely by scientists, medical practitioners, and medical officials. Although the number of cases of Omicron detected in India are just above 100 now, there may be a good chance of it increasing exponentially in the next couple of months.
While the Omicron variant has already made its entry into India, it is supposed to have originated from South Africa, and officially been identified in Botswana.
Soon after the identification of this new variant of COVID-19 by a team in Botswana headed by Dr Sikhulile Moyo, the World Health Organisation (WHO) did not hesitate to classify it as a Variant Of Concern (VOC). The reason that the WHO has classified this variant of COVID-19 as a VOC is because of the high number of mutations and its rate of transmission. Soon after, many other countries also identified this new variant affecting their population.
Do not hesitate to get an RT-PCR for diagnosis of Covid even if you experience mild symptoms and no fever. Early identification, self-isolation and treatment can play a significant role at this time.
Although the most recent data suggests that the Omicron variant has much higher transmissibility than even the previously deadly Delta variant, it does not seem to be overloading hospitals yet. The latest data points out that even though more than 50,000 cases have been reported in the last couple of weeks in the origin country of this variant, the number of deaths reported due to Omicron is significantly low.
This naturally poses questions about the transmissibility and the severity of this mutation of the Coronavirus.
Based on statistical data from South Africa, the epicentre of this new mutation, it has been assumed that the Omicron variant is 3 times more capable of infecting other people as compared to the delta variant. Moreover, the rate of increasing cases has surpassed that of the previous 3 waves of COVID-19 as well.
At the other end of the globe, Japanese researchers have been able to confirm that the Omicron variant is 4.2 times more transmissible than previously reported variants. Apart from the countries in the African continent, this new mutation has penetrated the populations of the UK and other European countries as well. More than 77 countries have reported Omicron cases so far. There can also be a case that some countries may have undetected cases of Omicron spreading. What is more alarming is the fact that the number of cases has been seen to be doubling every 1.5 to 3 days.
Also read: Chamoy Benefits: A Research-Backed Health And Flavour Guide
Most patients in the affected regions of Africa have reported mild to severe headaches, scratchy throat, body aches and a constant sense of fatigue. This is a stark contrast to the symptoms reported by patients during the Delta wave (which included fluctuating pulse rates and respiratory trouble). However, it is important to note that it is too early to comment anything on the presentation and severity of this variant. There are reports on cases with severe symptoms and fatal consequences as well.
World Health Organisation says not to take this variant lightly because-
A high number of mutations in the spike protein of Omicron has raised a question on the efficacy of existing Covid vaccines. There are no studies so far to show the inefficiency of vaccines so far. There can be some variation in the efficacy but vaccines are definitely going to help. Also, delta is still the dominant variant so irrespective of the variant type we need to get ourselves vaccinated and follow steps to reduce our risk of exposure.
Also Read: Is Covishield Effective Against Omicron Variant?
While the transmissibility of this new variant currently seems much higher than any previous variants of the Coronavirus, it is important to remember that timely medical intervention is the key. And more important is to prevent the spread of COVID-19 by getting vaccinated and following all the safety measures sincerely. On a positive note, we are all well versed with Covid-appropriate behaviour by now and can play a heroic role in reducing the spread of Covid infections in our region.
Whatever it may be, it is always important to eat a nutritious diet rich in antioxidants and exercise regularly, to help boost your body’s natural immunity. This can, to a great extent, help your body fight off the infection and suppress any life-threatening symptoms.
Read More: Precautions to Take Against The Omicron Variant
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
When the world had started believing that COVID-19 is about to enter the endemic stage, the virus has struck back with a brand new variant named Omicron, also known as B.1.1.529. The new variant has reignited the speculations over the emergence of a third COVID-19 wave in India, which can completely disrupt our life. As per the initial research, the new variant has a high amount of spike mutations that were never recorded before.
Omicron seems to be very rampant in terms of spreading as its cases did not take many days to pop up in many other countries after first being reported in South Africa. The World Health Organisation (WHO) has listed Omicron as a “variant of concern”.
The newest variant of SARS-CoV-2 was first reported to the WHO on November 24, 2021. The variant was detected in the specimen collected on November 11 in Botswana and on November 14 in South Africa.
Soon after receiving the report, WHO classified Omicron as a variant of concern on November 26, followed by the United States on November 30 before the country recorded its first case on December 1. The next day, India recorded its first two cases of the Omicron variant.
With the limited number of cases recorded so far, there is only a little information available about the symptoms. It has been said that the Omicron variant can present itself with extreme tiredness, body aches, throat discomfort (scratching or soreness), fever and some headache.
As the number of cases has been very low so far, there can be a possibility of this strain presenting severe symptoms in some people. Hence, experts are suggesting not to take this variant lightly.
The Omicron variant likely will spread more easily than some of the previous variants of the SARS-CoV-2 virus and how easily Omicron spreads compared to Delta remains unknown. More data are needed to know if Omicron infections and especially reinfections and breakthrough infections in people who are fully vaccinated, cause more severe illness or death than infection with other variants. Scientists are working to determine how well existing treatments for COVID-19 work. Based on the changed genetic make-up of Omicron, some treatments are likely to remain effective while others may be less effective.
Current vaccines are expected to protect against severe illness, hospitalizations and deaths due to infection with COVID-19 and also the Omicron variant. However, breakthrough infections in people who are fully vaccinated are likely to occur. With other variants, like Delta, vaccines have remained effective at preventing severe illness, hospitalizations and death. The recent emergence of Omicron further emphasizes the importance of vaccination and boosters.
Scientists are working to learn more about the Omicron variant to better understand how easy it might be transmitted and the effectiveness of currently authorized or approved medical countermeasures, such as vaccines, therapeutics and diagnostic tests, against this variant. New information about the virologic, epidemiologic and clinical characteristics of the Omicron variant is rapidly emerging. Scientific bodies recommend wearing a mask in public indoor settings in areas of substantial or high community transmission, regardless of vaccination status.
Disclaimer: The information included at this site is for educational purposes only and is not intended to be a substitute for medical treatment by a healthcare professional. Because of unique individual needs, the reader should consult their physician to determine the appropriateness of the information for the reader’s situation.
COVID-19 has changed us in more ways than we can count. One of the things that are not widely discussed is how it has affected family dynamics. Human beings are meant to live in social environments, mingle with loved ones and strike a balance between company and solitude. It keeps introverts, extroverts and ambiverts psychologically healthy.
But the pandemic and the ensuing lockdown, partial home isolation and online schooling, lack of outings and outdoor activities, working from home meant we have been cooped up inside our homes and not been able to see or spend time with many of our loved ones.
Add to that the threat of contracting the viral disease and the constant news of people we know succumbing to coronavirus ensured that our mental health went into a tailspin.
But someone in your family has been more adversely affected than you. It’s the youngest and most curious member of your family. It’s your child!
Children have not been able to go to school for months. The routine they were used to has been interrupted. Children have a harder time acclimatizing to change than adults.
They are lonely because they are cut off from their friends. They miss their teachers.
And all that stress related to your job, finances, health issues that you and the parents have been experiencing is unknowingly transmitted to them.
Your behaviour changes when you are under stress. Despite trying to be on your best behaviour, you will be short-tempered, agitated and irritable. That makes your child feel more ill at ease.
This psychological disturbance manifests in many ways. Your child might show signs of hyperactivity, noisiness, inattentiveness, rebelliousness and rude behaviour.
Instead of further losing your temper with them or handing out harsh punishments, you need to understand that you need to calm your child down. Put his/her mind at ease with love and the feeling of certainty. Only then will your child feel secure enough to be a better version of himself/herself.
The way to calm your child down is by being a more attentive and understanding parent. Yes, you are stressed out yourself but you need to understand that children are more vulnerable and less equipped to cope with stress. Their reasons for feeling anxious, unhappy and depressed are just as valid as yours. They need your help.
1. Listen to them
Many problems can be solved through open and clear communication where children do not fear being judged or punished by their parents. Be open to them and let them know that whatever is on their mind, they can share with you.
Discuss the problems they might be facing due to online schooling and help them in overcoming the hurdles.
2. Do not brush aside their pain
Adults have a habit of laughing off children’s problems. The things that cause children distress are not insignificant. They need to be addressed if you want your child to grow up into an emotionally and psychologically healthy human. Even if you feel like the pandemic has heaped your plate with problems, you will still have to find time to solve your child’s problems.
3. Do not fight or argue with them
Children may demand things that you possibly cannot grant during the pandemic such as birthday parties, picnics or sleepovers with friends. Instead of hushing their temper tantrums with a fierce scolding, try engaging in a logical dialogue with them. Children do understand the reason if approached calmly and treated as an adult (and not disdainfully as some adults treat children).
4. Let them stay in touch with all their loved ones
The biggest boon of technology is the ease of connectivity. It is only natural for children during the pandemic to be worried about the health of their grandparents and friends. So arrange video calls with people they care about on a regular basis.
5. Give them hope
Children often act out when they are scared and uncertain. This is why you need to make them feel protected. Even though you are grappling with the same emotions of fear and uncertainty, you need to make your children feel that they are protected and that as a parent, you will try to shield him/her as much as possible.
6. Establish a steady routine in your home
Nothing is more calming and assuring than a fixed routine. So, try implementing one and it should also involve the adults of the family. Try to stick to a routine when it comes to waking up in the morning, breakfast, chores, work, lunch, naptime, online classes and homework (for the children), dinner and bedtime.
7. Family time
Quality time with the family is another effective strategy to make your child feel calm, tranquil and loved. Ensure that you all engage in some family activity every day. Be it board games, watching sports or cartoons or asking them to help you with household chores, make sure they feel involved and cherished.
8. Discipline them
Children have very little idea of what kind of behaviour is acceptable or unacceptable. But during the modern age and especially considering how stressful the current era is, disciplining is something you need to approach thoughtfully. The old methods of physically punishing the child, yelling and abusing have been proven to do a lot of long-term damage.
Reward positive behaviour with acknowledgement and praise. Unless they do something that is worthy of punishment, ignore them. That usually discourages them from repeating the act.
Disciplining goes a long way in teaching children to be in greater control over unpleasant emotions such as turbulence, anger, hopelessness and despair.
Also Read: Constipation in Kids: A Research-Based Guide for Parents
Parenting has never been easy and the challenges have increased many-fold because of the ongoing pandemic. But it is only through affection, care and understanding can we all improve our psychological health and children need all three desperately. Once they start feeling sheltered, protected and understood, they will naturally calm down.
Every child is different, if you notice the persistence of any significant behaviour changes – irritability, loneliness, nightmares, change in appetite and sleep patterns, loss of interest in activities they loved previously, unexplained aches and pains, sadness do not hesitate in consulting a child psychologist or psychiatrist for the right advice. Anxiety and depression are found in people of all age groups including the little ones. Do not take their mental health lightly and give them the right care.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
Next Page »« Previous Page